Eliksir-Pharmsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-04-27
Share capital
200,000.00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-64772-29496-UWRWD-34

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 17 days late).

  • 202510/05/2026
  • 202402/07/2025
  • 202315/05/2024
  • 202226/06/2023
  • 202101/08/2022
  • 202011/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 16%
Division · Retail trade1,354 / 9,913
Top 14%
City · Łódź493 / 8,065
Top 6.1%
Voivodeship · Łódzkie1,263 / 15,300
Top 8.3%
Country · Poland23,902 / 297,935
Top 8.0%

Results vs industry

Revenue
This companyUSD 7.59mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 206.60kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 7.29mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.78mMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Eliksir-Pharm has been an NFZ healthcare provider since 2024. In 2026 it is performing 3 contracts with a total value of USD 634.79. All its contracts were worth USD 1.14k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmeswielkopolskie1USD 634.79
Other services provided in pharmacieswielkopolskie2USD 0.00

Trademarks

Eliksir-Pharm holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2015.

MarkNumberClassesStatusProtected until
Eliksir lokalna sieć aptekZ.49380035Protected Dec 13, 2028
acti>witamina cZ.4462435Expired –
MarkProtected until
Eliksir lokalna sieć aptekDec 13, 2028
acti>witamina c–

Authorized Representatives

Rafał Emil Jarząbek – Vice President of the Management Board
Igor Jachorski – President of the Management Board
Paulina Świderek – Vice President of the Management Board

Manner of representation

In the case of appointment of a multi-member management board, two members of the management board acting jointly or one member of the management board acting together with a commercial proxy are authorized to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
480$12,965.9624%
1,520$41,058.8976%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-05-04.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

34 public aid cases recorded, with a total value of $187,447.

PurposeGross amount
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$202
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$202
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$202

Competitors

Name
MybestpharmS.A.
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Pikadasp. z o.o.
Awicennasp. j.

Change history

DateEvent
2025-01-15Address change
2025-01-15PKD change
2018-12-03Address change
2018-12-03PKD change
2017-04-27Entered in the register

FAQ

Last updated: 2026-05-10